NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+304.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.42B
AUM Growth
+$387M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
18
New
Increased
Reduced
Closed

Top Buys

1 +$22.6M
2 +$15.6M
3 +$7.38M
4
CRVS icon
Corvus Pharmaceuticals
CRVS
+$7.18M
5
ENGN icon
enGene Therapeutics
ENGN
+$1.78M

Top Sells

1 +$14M
2 +$479K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$32.9B
$739M 52.02%
7,601,087
TYRA icon
2
Tyra Biosciences
TYRA
$1.75B
$155M 10.93%
4,055,861
TNGX icon
3
Tango Therapeutics
TNGX
$3.13B
$152M 10.7%
7,266,081
ORIC icon
4
Oric Pharmaceuticals
ORIC
$776M
$90.8M 6.39%
7,162,637
ALMS
5
Alumis Inc
ALMS
$2.57B
$78M 5.49%
3,540,998
+625,000
RLAY icon
6
Relay Therapeutics
RLAY
$3.35B
$55M 3.87%
5,526,506
+825,000
ZYME icon
7
Zymeworks
ZYME
$1.79B
$27.9M 1.96%
1,113,946
KYMR icon
8
Kymera Therapeutics
KYMR
$6.04B
$23.2M 1.63%
278,896
CTMX icon
9
CytomX Therapeutics
CTMX
$708M
$20.9M 1.47%
+4,449,932
CNTX icon
10
Context Therapeutics
CNTX
$218M
$19.4M 1.37%
7,419,355
CGEM icon
11
Cullinan Oncology
CGEM
$934M
$16.2M 1.14%
1,141,145
ENGN icon
12
enGene Therapeutics
ENGN
$115M
$15.8M 1.11%
2,324,943
+200,000
CRVS icon
13
Corvus Pharmaceuticals
CRVS
$971M
$6.58M 0.46%
+450,000
ARVN icon
14
Arvinas
ARVN
$505M
$5.72M 0.4%
539,394
SLN
15
Silence Therapeutics
SLN
$299M
$5.02M 0.35%
952,400
GLUE icon
16
Monte Rosa Therapeutics
GLUE
$1.51B
$5M 0.35%
304,237
+25,000
SPRY icon
17
ARS Pharmaceuticals
SPRY
$876M
$4.9M 0.35%
610,703
-50,000
MRSN
18
DELISTED
Mersana Therapeutics
MRSN
-482,689